Haemonetics (HAE) Expands VASCADE Line With New Limited Launch

The latest development is expected to help Haemonetics grab opportunities in the growing vascular closure solutions space. Earlier this year, VASCADE MVP XL system gained pre-market approval from the U.S. Food and Drug Administration. VASCADE MVP XL, while including closure solutions for procedures requiring 10-12F sheaths, is anticipated to upgrade the existing range of vascular closure solutions to cater to the increasing demand for catheter-based ablation technologies. Haemonetics is confident about impr ...